Neurodevelopmental problems and quality of life in 6-year-olds with a history of developmental language disorder.


Journal

Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968

Informations de publication

Date de publication:
Jan 2022
Historique:
revised: 18 08 2021
received: 05 01 2021
accepted: 10 09 2021
pubmed: 14 9 2021
medline: 28 1 2022
entrez: 13 9 2021
Statut: ppublish

Résumé

To explore family-reported neurodevelopmental functioning and quality of life in 6-year-olds who had screened positive for developmental language disorder at age 2.5 years. Parents of 85 6-year-old children completed questionnaires about child neurodevelopmental difficulties and quality of life. The children were interviewed regarding quality of life, and their language was assessed by speech and language pathologists. Test results at 6 years identified three subgroups: children with developmental language disorder (n = 68) or speech sound disorder (n = 6) and children with no current language disorder (n = 11). Out of the 68 children with developmental language disorder, 33 (48%) had significant parent-rated problems with language, executive functions 17 (25%), perception 15 (22%) and/or motor skills 15 (22%). Four (67%) of the children with speech sound disorder had significant problems with language. Significant problems were reported with language in five (45%) and with perception in four (36%) children with no current language disorder. The parents reported no impaired quality of life, whereas the children themselves reported impairment mainly with school functioning. Overlap between language difficulties and other neurodevelopmental problems was higher in 6-year-olds who had screened positive for developmental language disorder about 3 years earlier, than in the general population. The parent and child reports of quality of life were not consistent.

Identifiants

pubmed: 34516681
doi: 10.1111/apa.16104
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115-122

Subventions

Organisme : Agreement on Medical education and Research ALF of the Sahlgrenska University Hospital, Gothenburg, Sweden
Organisme : The Petter Silfverskiöld Memorial Foundation.
Organisme : The Local Research and Development Council Gothenburg and Södra Bohuslän, Gothenburg, Sweden

Informations de copyright

© 2021 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Références

Norbury CF, Gooch D, Wray C, et al. The impact of nonverbal ability on prevalence and clinical presentation of language disorder: evidence from a population study. J Child Psychol Psychiatry. 2016;57(11):1247-1257.
Bishop DV, Snowling MJ, Thompson PA, Greenhalgh T. Catalise-2 consortium. Phase 2 of CATALISE: a multinational and multidisciplinary Delphi consensus study of problems with language development: terminology. J Child Psychol Psychiatry. 2017;58(10):1068-1080.
Horowitz L, Westlund K, Ljungberg T. Aggression and withdrawal related behavior within conflict management progression in preschool boys with language impairment. Child Psychiatry Hum Dev. 2007;38(3):237-253.
Ek U, Norrelgen F, Westerlund J, Dahlman A, Hultby E, Fernell E. Teenage outcome after speech and language impairment at preschool age. Neuropsychiatr Dis Treat. 2012;8:221.
Dubois P, St-Pierre MC, Desmarais C, Guay F. Young adults with developmental language disorder: a systematic review of education, employment and independent living outcomes. J Speech Lang Hear Res. 2020:63(11):3786-3800.
Jansson A, Larsson AK, Cavefors AS, et al. Annual Child Health Care report statistics 2017. Gothenburg: Region Västra Götaland; 2017.
Miniscalco C, Nygren G, Hagberg B, Kadesjö B, Gillberg C. Neuropsychiatric and neurodevelopmental outcome of children at age 6 and 7 years who screened for language problems at 30 months. Dev Med Child Neurol. 2006;48(5):361-366.
Mueller KL, Tomblin JB. Examining the comorbidity of language disorders and ADHD. Top Lang Disord. 2012;32(3):228-246.
Miniscalco C, Fernell E, Thompson L, Sandberg E, Kadesjö B, Gillberg C. Development problems were common five years after positive screening for language disorders and or, autism at 2.5 years of age. Acta Paediatr. 2018;107(10):1739-1749.
Gillberg C. The ESSENCE in child psychiatry: early symptomatic syndromes eliciting neurodevelopmental clinical examinations. Res Dev Disabil. 2010;31(6):1543-1551.
Lambek R, Trillingsgaard A. Elaboration, validation and standardization of the five to fifteen (FTF) questionnaire in a Danish population sample. Res Dev Disabil. 2015;8:161-170.
Kadesjö B, Janols LO & Korkman M et al. Five-To-Fifteen-Revised (5-15R) 2017. Available from www.5-15.org. (Accessed 03-12-2018).
Schachinger-Lorentzon U, Kadesjö B, Gillberg C, Miniscalco C. Children screening positive for language delay at 2.5 years: language disorder and developmental profiles. Neuropsychiatr Dis Treat. 2018;14:3267-3277.
Korkman M, Jaakkola M, Ahlroth A, Pesonen AE, Turunen MM. Screening of developmental disorders in five-year-olds using the FTF (Five to Fifteen) questionnaire: a validation study. Eur Child Adolesc Psychiatry. 2004;13(3):iii31-iii38.
Stübner C, Flynn T, Gillberg C, Fernell E, Miniscalco C. Schoolchildren with unilateral or mild to moderate bilateral sensorineural hearing loss should be screened for neurodevelopmental problems. Acta Paediatr. 2020;109(7):1430-1438.
Coghill D, Danckaerts M, Sonuga-Barke E, Sergeant J. Practitioner review: quality of life in child mental health-conceptual challenges and practical choices. J Child Psychol Psychiatry. 2009;50(5):544-561.
Wallander JL, Koot HM. Quality of life in children: a critical examination of concepts, approaches, issues and future directions. Clin Psychol Rev. 2016;45:131-143.
Feenye R, Desha L, Khan A, Ziviani J. Contribution of speech and language difficulties to health-related quality-of-life in Australian children: a longitudinal analysis. Int J Speech Lang Pathol. 2017;19(2):139-152.
Eadie P, Conway L, Hallenstein B, Mensah F, Mckean C, Reilly S. Quality of life in children with developmental language disorder. Int J Lang Commun Disord. 2018;53(4):799-810.
Nicola K, Watter P. The comparison of perceived health-related quality of life between Australian children with severe specific language impairment to age and gender-matched peers. BMC Ped. 2018;18(1):62.
Le HND, Le LKD, Nguyen PK, et al. Health-related quality of life, service utilization and costs of low language: a systematic review. Int J Lang Commun Disord. 2020;5(1):3-25.
Varni JW, Seid M, Kurtin PS. PedsQL 4.0: reliability and validity of the pediatric quality of life inventory version 4.0 Generic Score Scales in healthy and patient populations. Med Care. 2001;39(8):800-812.
Bishop DV, Snowling MJ, Thompson PA, Greenhalgh TCATALISE. A multinational and multidisciplinary delphi consensus study. Identifying language impairments in children. PLoS One. 2016;11(7):e0158753.
Varni JW, Burwinkle TM, Seid M, Skarr D. The PedsQL 4.0 as a pediatric population health measure: feasibility, reliability, and validity. Ambul Pediatr. 2003;3(6):329-341.
Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927;22(158):209-212.
Law J, Garrett Z, Nye C. Speech and language therapy interventions for children with primary speech and language delay or disorder. Cochrane Database Syst Rev. 2003;2003(3):CD004110.
Kadesjö B, Janols LO, Korkman M, et al. The FTF (Five to Fifteen): the development of a parent questionnaire for the assessment of ADHD and comorbid conditions. Eur Child Adolesc Psychiatry. 2004;13(3):iii3-iii13.

Auteurs

Simon Ottosson (S)

Department of Pediatrics, Angered Hospital Gothenburg, Angered, Sweden.

Ulrika Schachinger Lorentzon (U)

Gillberg Neuropsychiatry Centre, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Pediatric Speech and Language Pathology, Queen Silvia Children's Hospital Gothenburg, Gothenburg, Sweden.

Björn Kadesjö (B)

Gillberg Neuropsychiatry Centre, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Christopher Gillberg (C)

Gillberg Neuropsychiatry Centre, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Child Neuropsychiatry, Queen Silvia Children's Hospital Gothenburg, Gothenburg, Sweden.

Carmela Miniscalco (C)

Gillberg Neuropsychiatry Centre, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Department of Pediatric Speech and Language Pathology, Queen Silvia Children's Hospital Gothenburg, Gothenburg, Sweden.
Department of Child Neuropsychiatry, Queen Silvia Children's Hospital Gothenburg, Gothenburg, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH